As reported in Globes: CEO Prof. Pnina Fishman: The treatment positions the company in the forefront of drug development for dry-eye syndrome. Can-Fite BioPharma Ltd. has obtained US Food and Drug Administration (FDA) approval for the Phase III clinical trial of its CF101 anti-inflammatory drug for the treatment of dry-eye syndrome. The trial will last for […]
In order to encourage large financial services companies and international banks to set up financial R&D centers in Israel, the Ministry of Finance and the Ministry of Industry, Trade, and Labor have established a special incentives program. The government will provide 40% of the plan’s total budget approved by the Office of the Chief Scientist […]
Categories
The Gene at the Heart of Pain
As reported in Israel 21C: A gene affecting chronic pain caused by nerve injury has been identified by Israeli and international researchers, opening the way for new treatment approaches. A gene associated with susceptibility to chronic pain caused by nerve injury in humans has been identified by a team of Israeli and international researchers, offering […]
Medical product giant Baxter International and Israeli biopharmaceutical company Kamada entered into a definitive distribution agreement for Glassia, the first and only liquid, ready-to-use Alpha1-Proteinase inhibitor that treats genetic lung-damaging disorder alpha-1 antitryspin (AAT). Baxter has committed to buying minimum quantities of Glassia worth around $60 million, and has secured exclusive marketing rights to Kamada’s […]
Privately held Quark Pharmaceuticals Inc licensed its experimental kidney drug to Swiss giant Novartis in a multi-million dollar deal. Novartis obtained the exclusive worldwide license to Quark’s experimental drug QPI-1002 for an upfront payment of $10 million, followed by a slate of milestone payments that could reach as high as $670 million based on developmental […]
Categories
Nutri Gal
NutriGal – a leading developer and manufacturer of premium soy based value added food ingredients, is a member of the Galam Group- Israel’s leading fructose Glucose and Starch manufacturer (www.galamgroup.com). Together with its ingredients NutriGal provides special know how and patented innovative solutions for a wide range of premium applications for the healthy food industry, […]
From Port2Port: This year that date falls on the afternoon of 8th September 2010 and continues until the evening of 10th September 2010, which is also Sabbath eve The Jewish New Year is celebrated on the first and second days of the Hebrew month of Tishrei. This year that date falls on the afternoon of […]
As reported by IVC: Avi Hasson will be expected to focus more on cleantech and life sciences. Minister of Industry, Trade and Labor Binyamin Ben-Eliezer has proposed Gemini Partners general partner Avi Hasson as the next Chief Scientist. He will submit Hasson’s name for government approval in the next few days. If Hasson is approved […]
As reported by IVC: The Chief Scientist will help Abbott find Israeli drug development technologies. The Office of the Chief Scientist has signed an R&D cooperation deal with US pharmaceutical and medical devices company Abbott Laboratories Inc. (NYSE: ABT). Abbott is the 19th foreign company that has signed an R&D cooperation deal with Israel. The […]
As reported by IVC: Representatives of German electronics giant meet Israeli delegation in Berlin. Manufacturers Association president says 90% foreign investments from US, only 10% from Europe. ‘it’s time Europeans saw Israeli potential,’ he adds BERLIN – German electronics giant Siemens is considering investing considerable capital in Israel, according to recent meetings in Germany between […]
israeltrade.org.au 